Russell Alan J (CIK 1853529) reported 19 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy EWTX (5,781 shares), Buy EWTX (7,031 shares), Sell EWTX (3,238 shares), Sell EWTX (2,273 shares), Sell EWTX (390 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Buy | 5,781 | $0 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Buy | 7,031 | $0 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Sell | 3,238 | $141,428 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Sell | 2,273 | $99,275 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Sell | 390 | $17,339 |
| 2026-07-02 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Buy | 130,352 | $58,658 |
| 2026-07-02 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Buy | 69,648 | $12,537 |
| 2026-07-02 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Sell | 130,352 | $5.1M |
| 2026-07-02 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Sell | 69,648 | $2.7M |
| 2025-11-13 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Buy | 100,000 | $18,000 |
| 2025-11-13 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Sell | 100,000 | $2.1M |
| 2025-08-28 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Buy | 100,000 | $18,000 |
| 2025-08-28 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Sell | 100,000 | $1.5M |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Buy | 5,781 | $0 |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Sell | 1,907 | $25,535 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Buy | 5,209 | $0 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Sell | 1,551 | $25,514 |
| 2025-03-11 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Buy | 200 | $36 |
| 2025-03-11 | Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer | Sell | 200 | $6,004 |
Source: SEC Form 4 filings · as of 2026-08-14